PURPOSE: To evaluate the efficacy of medium-dose UVA1 phototherapy in @entity1 with @entity2631 . METHOD: A controlled pilot study with medium-dose UVA1 (48 J/cm2) was performed. The results were evaluated by means of a skin score and two objective methods for quantifying @entity1463 (cutometer and fast Fourier transform method). @entity1 were treated 4 times a week for 5 weeks. The follow-up period was 12 weeks. RESULTS: All @entity1 responded to therapy. Skin score and cutometer results showed improvement of skin elasticity of treated skin compared to control skin. Fast Fourier transform measurements showed no change in bundle orientation ratio and spacing. CONCLUSION: We concluded that treatment for 12 weeks 4 times a week with medium-dose UVA1 may be a beneficial therapy and a well-tolerated treatment modality for @entity2631 ( @entity2631 ). After 12 weeks, improvement of @entity272 can be detected by skin score and cutometer measurements but not by the fast Fourier transform method.

Evaluation of medium-dose UVA1 phototherapy in XXXX with the cutometer and fast Fourier transform method.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity1463 :: ('MESH:D012598', 'Disease') :: ['sclerosis'] @entity2631 :: ('MESH:D012594', 'Disease') :: ['localized scleroderma', 'morphea'] @entity272 :: ('MESH:D012871', 'Disease') :: ['skin sclerosis']
@entity2631 :: (MESH:D012594,Disease) :: ['localized scleroderma']
